Logo

American Heart Association

  2
  0


Final ID: 4169555

The impact of carbon monoxide to determine the in-hospital prognosis of myocardial infarction

Abstract Body (Do not enter title and authors here): INTRODUCTION: Smoking and air pollution produce carbon monoxide (CO), which sharply reduces blood oxygen carrying capacity and may worsen myocardial infarction (MI). We aimed to assess the prognostic value of expiratory CO level in patients hospitalized for MI.
METHODS: In this prospective nation-wide cross sectional study, expiratory CO levels were measured upon admission in consecutive patients hospitalized for MI across 39 centers. In accordance with previous studies, a CO threshold of 11 ppm was defined to classify patients as low or high CO level. The primary outcome was in-hospital major adverse events (MAEs: death, severe ventricular arrythmia, cardiogenic shock and mechanical ventilation). The secondary outcomes were 1-year MACEs (cardiovascular death and recurrent MI) and 1-year all-cause mortality. The importance of CO in determining events was stratified using machine learning (ML) analysis.
RESULTS: Among 717 patients (64±13 years; 75% males; 33% active smokers; 43% ST elevation MI), 11% of the population had elevated expiratory CO level (> 11 ppm). Among patients with CO > 11 ppm, there was a significant trend between CO level and rate of in-hospital MAEs (10% in the 1st tertile and 55% in the 3rd tertile of elevated CO levels; p for trend=0.002; Figure 1). After adjustment for confounders, including smoking status, elevated CO levels were independently associated with a significant increase in MAEs: odds ratio (OR) [95% confidence interval]: 7.5 [3.5-16.7] adjusting for comorbidities, 14.0 [6.1-33.3] for parameters of in-hospital severity, and 12.7 [5.6-29.6] for respiratory parameters. Elevated CO levels were associated with 1-year MACEs and all-cause deaths after adjustment for confounders (Figure 2). No significant differences in coronary angiographic characteristics were noted in patients with elevated CO levels. ML analysis showed that elevated CO level was the most ranking predictor of MAEs as well as one of the best predictors of 1-year MACEs and all-cause mortality (Figure 3). When CO was compared to the predictive value of the parameters used to calculate the GRACE score in our population, it ranked as the strongest predictor of in-hospital events.
CONCLUSION: This is the first prospective study to show that elevated expiratory CO levels upon admission were associated with a significant increase in in-hospital MAEs, 1-year MACEs and all-cause mortality in patients with MI. ML analysis ranked CO as a powerful predictor of these events.
  • Singh, Manveer  ( Lariboisière Hospital , Paris , France )
  • Gerbaud, Edouard  ( Bordeaux University , Pessac , France )
  • Millischer, Damien  ( Hôpital MONTFERMEIL , Monterfermeil , France )
  • El Ouahidi, Amine  ( University Hospital of Brest , Brest , France )
  • Bouali, Nabil  ( CHU de Strasbourg , Strasbourg , France )
  • Gall, Emmanuel  ( Lariboisière Hospital , Paris , France )
  • Thuaire, Christophe  ( Centre Hospitalier de Chartres , Chartres , France )
  • Roubille, François  ( CHU Montpellier , Montpellier , France )
  • Noirclerc, Nathalie  ( Centre hospitalier Annecy Genevois , Epagny Metz-Tessy , France )
  • Andrieu, Stephane  ( Hôpital Henri Duffaut , Avignon , France )
  • Fauvel, Charles  ( Rouen University Hospital , ROUEN , France )
  • Lequipar, Antoine  ( Lariboisière Hospital , Paris , France )
  • Dib, Jean-claude  ( Clinique A. Pare , Neuilly , France )
  • Lafont, Alexandre  ( Lariboisière Hospital , Paris , France )
  • El Beze, Nathan  ( Lariboisière Hospital , Paris , France )
  • Alizadeh, Charly  ( Lariboisière Hospital , Paris , France )
  • Guiraud-chaumeil, Paul  ( Lariboisière Hospital , Paris , France )
  • Florence, Jeremy  ( Lariboisière Hospital , Paris , France )
  • Toupin, Solenn  ( Lariboisière Hospital , Paris , France )
  • Vicaut, Eric  ( Unité de Recherche Clinique , Paris , France )
  • Pezel, Theo  ( Lariboisière Hospital , Paris , France )
  • Henry, Patrick  ( Lariboisière Hospital , Paris , France )
  • Dillinger, Jean-guillaume  ( Lariboisière Hospital , Paris , France )
  • Trimaille, Antonin  ( CHU de Strasbourg , Strasbourg , France )
  • Bouleti, Claire  ( University Hospital of Poitiers , Poitiers , France )
  • Delmas, Clement  ( Rangueil University Hospital , Toulouse , France )
  • Schurtz, Guillaume  ( University Hospital of Lille , Lille , France )
  • Houssany-pissot, Sonia  ( Hospital of Percy , Clamart , France )
  • Rossanaly Vasram, Reza  ( Felix-Guyon University Hospital , Saint-Denis-de-la-Reunion , France )
  • Author Disclosures:
    Manveer Singh: DO NOT have relevant financial relationships | Edouard GERBAUD: DO NOT have relevant financial relationships | Damien Millischer: No Answer | amine el ouahidi: No Answer | Nabil BOUALI: DO NOT have relevant financial relationships | Emmanuel Gall: No Answer | Christophe Thuaire: No Answer | François Roubille: No Answer | Nathalie Noirclerc: No Answer | Stephane Andrieu: No Answer | Charles Fauvel: DO have relevant financial relationships ; Consultant:Janssen:Active (exists now) ; Speaker:Alnylam:Past (completed) ; Speaker:Zoll:Past (completed) ; Speaker:AstraZeneca:Past (completed) ; Research Funding (PI or named investigator):Novartis:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Past (completed) | Antoine Lequipar: DO NOT have relevant financial relationships | Jean-Claude DIB: No Answer | Alexandre Lafont: DO have relevant financial relationships ; Consultant:Biotronik:Past (completed) ; Consultant:B Braun:Past (completed) | Nathan El Beze: No Answer | Charly Alizadeh: No Answer | Paul Guiraud-Chaumeil: No Answer | Jeremy Florence: DO NOT have relevant financial relationships | Solenn Toupin: No Answer | Eric VICAUT: No Answer | Theo Pezel: No Answer | Patrick Henry: No Answer | Jean-Guillaume DILLINGER: DO NOT have relevant financial relationships | Antonin Trimaille: DO NOT have relevant financial relationships | Claire Bouleti: No Answer | Clement Delmas: DO have relevant financial relationships ; Consultant:ABOTT:Active (exists now) ; Speaker:ABIOMED:Active (exists now) | Guillaume Schurtz: DO NOT have relevant financial relationships | Sonia Houssany-Pissot: No Answer | Reza Rossanaly Vasram: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Novel Insights in Cardiovascular Interventional Outcomes

Monday, 11/18/2024 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Cardiac Rupture as a Life-Threatening Outcome of Takotsubo Syndrome: A Systematic Review.

Denicolai Martin, Morello Matteo, Del Buono Marco, Sanna Tommaso, Agatiello Carla, Abbate Antonio

12-lead electrocardiograms predict adverse cardiovascular outcomes of emergency department patients

Haimovich Julian, Kolossvary Marton, Alam Ridwan, Padros I Valls Raimon, Lu Michael, Aguirre Aaron

More abstracts from these authors:
External validation and comparison with REVEAL 2.0 of the 6-strata system for risk stratification in PAH: are we reinventing the wheel?

Fauvel Charles, Liu Yongqi, Correa-jaque Priscilla, Everett Allen, Kanwar Manreet, Vanderpool Rebecca, Sahay Sandeep, Benza Raymond

A refined definition for low-risk pulmonary arterial hypertension patients including mortality and morbidity

Fauvel Charles, Liu Yongqi, Correa-jaque Priscilla, Everett Allen, Kanwar Manreet, Vanderpool Rebecca, Sahay Sandeep, Lin Shili, Benza Raymond

You have to be authorized to contact abstract author. Please, Login
Not Available